Business Context and Reporting Period
Company: Immuron Ltd (Immuron Limited)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of December 2025
Date of Filing: December 5, 2025
Principal Executive Office: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
This filing serves to report a specific corporate announcement made to the Australian Securities Exchange (ASX) regarding an application for the quotation of securities.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a procedural report regarding a securities application and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial performance or operations are reported in this document. The primary event is the submission of an "Application for quotation of securities" to the ASX.
Guidance, Outlook, and Risks
Management Commentary: The filing includes an explanatory note stating that the Company published one announcement titled "99.1 Application for quotation of securities."
Risks and Contingencies: The filing does not disclose specific risks, contingencies, or unusual items. It includes a standard disclaimer that the report shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the details of the "Application for quotation of securities" referenced in Exhibit 99.1.
- Confirm the status of the securities application with the Australian Securities Exchange (ASX).
- Review the attached Public Notice (Exhibit 99.1) for specific terms of the securities being quoted.
- Note that this filing does not contain updated financial results; refer to the most recent Form 20-F or ASX announcements for financial data.